Related Experiment Video
Updated: Nov 3, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Identifying an lncRNA-Related ceRNA Network to Reveal Novel Targets for a Cutaneous Squamous Cell Carcinoma
Yaqin Xu1, Yingying Dong1, Yunhua Deng1
1Department of Dermatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
A cutaneous squamous cell carcinoma (cSCC) derived from keratinocytes is the second most common cause of non-melanoma skin cancer. The accumulation of the mutational burden of genes and cellular DNA damage caused by the risk factors (e.g., exposure to ultraviolet radiation) contribute to the aberrant proliferation of keratinocytes and the formation of a cSCC. A cSCC encompasses a spectrum of diseases that range from recursor actinic keratosis (AK) and squamous cell carcinoma (SCC) in situ (SCCIS) to invasive cSCCs and further metastatic SCCs. Emerging evidence has revealed that lncRNAs are involved in the biological process of a cSCC. According to the ceRNA regulatory theory, lncRNAs act as natural miRNA sponges and interact with miRNA response elements, thereby regulating the mRNA expression of their down-stream targets. This study was designed to search for the potential lncRNAs that may become potential therapeutic targets or biomarkers of a cSCC. Considering the spirit of the study to be adequately justified, we collected microarray-based datasets of 19 cSCC tissues and 12 normal skin samples from the GEO database (GSE42677 and GSE45164). After screening the differentially expressed genes via a limma package, we identified 24 differentially expressed lncRNAs (DElncRNAs) and 3221 differentially expressed mRNAs (DEmRNAs). The miRcode, miRTarBase, miRDB and TargetScan databases were used to predict miRNAs that could interact with DElncRNAs and DEmRNAs. A total of 137 miRNA-lncRNA and 221 miRNA-mRNA pairs were retained in the ceRNA network, consisting of 31 miRNAs, 11 DElncRNAs and 155 DEmRNAs. For the functional analysis, the top enriched biological process was enhancer sequence-specific DNA binding in Gene Ontology (GO) terms. The FoxO signaling pathway, autophagy and cellular senescence were the top enrichment terms based on a Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The combination of a STRING tool and Cytoscape software (plug-in MCODE) identified five core mRNAs and built a core mRNA-associated ceRNA network. The expression for five identified core mRNAs and their related nine lncRNAs was validated using the external dataset GSE7553. Finally, one lncRNA HLA-F-AS1 and three mRNAs named AGO4, E2F1 and CCND1 were validated with the same expression patterns. We speculate that lncRNA HLA-F-AS1 may sponge miR-17-5p or miR-20b-5p to regulate the expression of CCND1 and E2F1 in the cSCC. The present study may provide potential diagnostic and therapeutic targets for cSCC patients.
Insights
This study identifies long non-coding RNAs (lncRNAs) as potential biomarkers and therapeutic targets for cutaneous squamous cell carcinoma (cSCC). Researchers found that lncRNA HLA-F-AS1 may regulate key genes involved in cSCC development, offering new avenues for treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cutaneous squamous cell carcinoma (cSCC) is a prevalent non-melanoma skin cancer driven by genetic mutations and DNA damage.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their role in cSCC pathogenesis via competing endogenous RNA (ceRNA) regulatory networks.
- Identifying specific lncRNAs involved in cSCC can lead to novel diagnostic and therapeutic strategies.
Purpose of the Study:
- To identify differentially expressed lncRNAs (DElncRNAs) and messenger RNAs (DEmRNAs) in cSCC tissues compared to normal skin.
- To construct a ceRNA network to elucidate potential regulatory interactions between lncRNAs, microRNAs (miRNAs), and mRNAs in cSCC.
- To validate potential diagnostic and therapeutic targets for cSCC.
Main Methods:
- Utilized microarray datasets (GSE42677, GSE45164) from cSCC and normal skin samples.
- Employed bioinformatics tools, including limma, miRcode, miRTarBase, miRDB, and TargetScan, to identify DElncRNAs, DEmRNAs, and predict miRNA interactions.
- Constructed a ceRNA network and performed functional enrichment analyses (GO, KEGG), followed by validation using an external dataset (GSE7553).
Main Results:
- Identified 24 DElncRNAs and 3221 DEmRNAs between cSCC and normal tissues.
- Established a ceRNA network comprising 31 miRNAs, 11 DElncRNAs, and 155 DEmRNAs.
- Validated lncRNA HLA-F-AS1 and mRNAs AGO4, E2F1, and CCND1, suggesting HLA-F-AS1 may regulate E2F1 and CCND1 expression via specific miRNAs.
Conclusions:
- lncRNA HLA-F-AS1, along with mRNAs AGO4, E2F1, and CCND1, are potential diagnostic and therapeutic targets for cSCC.
- The study proposes a regulatory mechanism where HLA-F-AS1 acts as a miRNA sponge to modulate E2F1 and CCND1 expression, impacting cSCC development.
- These findings provide a foundation for developing novel targeted therapies for cutaneous squamous cell carcinoma.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

